The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.
Flu deaths have surpassed COVID-19 in California for the first time since the pandemic, with concerns over low vaccination rates and a likely severe flu season.